Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
6
×
boston blog main
clinical trials
life sciences
national blog main
sanofi
6
×
boston top stories
national top stories
cancer
deals
ipo
cancer drugs
fda
investing
new york blog main
new york top stories
san francisco blog main
san francisco top stories
alnylam pharmaceuticals
amgen
drug discovery
new york
novartis
revolution medicines
san francisco
startups
takeda pharmaceutical
the column group
third rock ventures
venture capital
warp drive bio
abbvie
agios pharmaceuticals
akouos
alirocumab
allergan
allosteric
amag pharmaceuticals
amunix
anirvan ghosh
What
medicines
6
×
ipo
cancer
deal
disease
drug
new
proteins
research
revolution
targets
years
acquire
acquisitions
address
adds
ago
agreed
allosteric
announced
billion
bio
brings
cancer’s
cash
ceo
cholesterol
clinic
collabs
company
company’s
compound
course
covid
daniel
despite
development
discover
elusive
experimental
Language
unset
Current search:
medicines
×
biotech
×
sanofi
×
@xconomy.com
4 years ago
HotSpot Therapeutics Adds $65M to Steer Allosteric Medicines to the Clinic
@xconomy.com
4 years ago
Bio Roundup: Gilead’s $4.9B Deal, COVID-19 Collabs, IPO Plans & More
@xconomy.com
4 years ago
Revolution Medicines IPO Reels In $238M to Take On RAS in Cancer
@xconomy.com
4 years ago
Revolution Medicines Maps Out an IPO to Reach Cancer’s Frontiers
@xconomy.com
4 years ago
Schrödinger Sets Course for IPO to Support Growing Internal Pipeline
@xconomy.com
4 years ago
Novartis to Acquire MedCo and FDA-Ready Cholesterol Drug for $9.7B